UK markets open in 5 hours 24 minutes
  • NIKKEI 225

    28,872.39
    +163.81 (+0.57%)
     
  • HANG SENG

    26,114.84
    +97.31 (+0.37%)
     
  • CRUDE OIL

    82.97
    +0.47 (+0.57%)
     
  • GOLD FUTURES

    1,786.90
    +5.00 (+0.28%)
     
  • DOW

    35,603.08
    -6.26 (-0.02%)
     
  • BTC-GBP

    45,634.99
    -1,991.05 (-4.18%)
     
  • CMC Crypto 200

    1,498.93
    -35.71 (-2.33%)
     
  • ^IXIC

    15,215.70
    +94.02 (+0.62%)
     
  • ^FTAS

    4,102.33
    -16.45 (-0.40%)
     

Global Viral Vectors and Plasmid DNA Manufacturing Market Forecasts 2021-2028: A USD 1,866.90 Million Market by 2028

·4-min read

Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Viral Vectors And Plasmid DNA Manufacturing Market Size By Product Type, By Application, By End Product, By Geographic Scope And Forecast" report has been added to ResearchAndMarkets.com's offering.

The Global Viral Vectors and Plasmid DNA Manufacturing Market was valued at USD 583.71 Million in 2020 and is projected to reach USD 1,866.90 Million by 2028, growing at a CAGR of 15.40% from 2021 to 2028.

A growing number of patients opting for gene therapy is a major factor propelling the growth of the Viral Vectors and Plasmid DNA Manufacturing market. Gene therapy is a leading field in medical science, which promises new treatment development for patients suffering from various disease. Genetically modified therapies have emerged as a promising treatment approach for various diseases (primarily ones that currently have no cure), including inherited disorders and certain viral infections. Demand for plasmid DNA is rising steeply because of a boom in gene therapy development.

This report provides an all-inclusive environment of the analysis for the Viral Vectors And Plasmid DNA Manufacturing Market. The market estimates provided in the report are the result of in-depth secondary research, primary interviews and in-house expert reviews. These market estimates have been considered by studying the impact of various social, political and economic factors along with the current market dynamics affecting the Viral Vectors And Plasmid DNA Manufacturing Market growth.

Along with the market overview, which comprises of the market dynamics the chapter includes a Porter's Five Forces analysis which explains the five forces: namely buyers bargaining power, suppliers bargaining power, threat of new entrants, threat of substitutes, and degree of competition in the Viral Vectors And Plasmid DNA Manufacturing Market. It explains the various participants, such as system integrators, intermediaries and end-users within the ecosystem of the market. The report also focuses on the competitive landscape of the Viral Vectors And Plasmid DNA Manufacturing Market.

The report will provide a valuable insight with an emphasis on the global market including some of the major players such as Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Cobra Biologics Ltd., Brammer Bio, Waisman Biomanufacturing, Genezen, YPOSKESI, Advanced BioScience, Laboratories, Inc. (ABL, Inc.), Novasep Holding S.A.S, ATVIO Biotech Ltd, and Others.


Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary
3.1 Market Overview
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Regional Insights
3.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Geographical Analysis
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market, by Product Type
3.5 Global Viral Vectors and Plasmid DNA Manufacturing Market, by Application
3.6 Global Viral Vectors and Plasmid DNA Manufacturing Market, by End Product
3.7 Future Market Opportunities
3.8 Global Market Split

4 Market Outlook
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Outlook
4.2 Market Drivers
4.2.1 Increasing Number of Patients Opting for Gene Therapy
4.2.2 Rising Prevalence of HIV/Aids and Growing R&D Funding from Several Organizations
4.3 Restraints
4.3.1 Manufacturing Challenges Pertaining to Large Scale Production of Vectors
4.4 Opportunities
4.4.1 Growing Healthcare Infrastructure and Government Support
4.4.2 Growing Number of Gene Therapy Candidates, Coupled With Their Rapid Progression Through Various Phases of Clinical Development
4.5 The Impact of Covid-19
4.6 Porters Five Force Model
4.7 Product Life Line

5 Market, by Product Type
5.1 Overview
5.2 Viral Vector
5.3 Plasma DNA
5.4 Non-Viral DNA Vectors

6 Market, by Application
6.1 Overview
6.2 Cancer
6.3 Inherited Disorder
6.4 Infectious Diseases
6.5 Others

7 Market, by End Product
7.1 Overview
7.2 DNA Vaccines
7.3 Gene Therapy
7.4 Immunotherapy
7.5 Others

8 Market, by Geography
8.1 Overview
8.2 North America
8.3 Europe
8.4 Asia-Pacific
8.5 Row

9 Competitive Landscape

10 Company Profiles

  • Merck KGaA

  • Lonza

  • FUJIFILM Diosynth Biotechnologies U.S.A. Inc.

  • Cobra Biologics Ltd.

  • Brammer Bio

  • Waisman Biomanufacturing

  • Genezen

  • YPOSKESI

  • Advanced BioScience

  • Laboratories Inc.

  • Novasep Holding S.A.S

  • ATVIO Biotech Ltd

For more information about this report visit https://www.researchandmarkets.com/r/e8yspl

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting